Home » Topics » BioWorld Science

BioWorld Science
RSS

IMMvention Therapeutix synthesizes NLRP3 inflammasome inhibitors

Nov. 17, 2021

Chinese researchers divulge GTPase KRAS mutant inhibitors

Nov. 17, 2021

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

Increased BMP-10 activity tied to disease severity in pulmonary hypertension

Nov. 17, 2021

Plexin D1-positive extracellular vesicles as potential biomarker of polymyositis and dermatomyositis

Nov. 17, 2021

Novel pan-ERR agonists can provide cardioprotection against heart failure

Nov. 17, 2021

IL-36-gamma is a marker of enthesitis-related arthritis

Nov. 17, 2021

Preclinical data presented on INBRX-121 as monotherapy or in combination with IO therapy regimens

Nov. 17, 2021

AASLD meeting: Cholangiocytes can induce liver regeneration

Nov. 16, 2021

Soluble ACE2 decoy peptide ameliorates SARS-CoV-2 lung vascular injury

Nov. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...